about
Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?Exome sequencing identifies mutations in ABCD1 and DACH2 in two brothers with a distinct phenotype.F2-dihomo-isoprostanes as potential early biomarkers of lipid oxidative damage in Rett syndrome.The absence of ABCD2 sensitizes mice to disruptions in lipid metabolism by dietary erucic acid.Adrenoleukodystrophy: a forgotten diagnosis in children with primary Addison's diseasePartial rescue of Rett syndrome by ω-3 polyunsaturated fatty acids (PUFAs) oilX-linked adult-onset adrenoleukodystrophy: Psychiatric and neurological manifestations.
P2860
Q27690256-A5AAA8B0-AA7B-4C90-A510-B2F26775894AQ35163395-2C685A44-AEBD-4326-9320-2C0456A8D9D3Q35768582-541EB877-7F7E-4054-AA0E-97CE66D7E31CQ35958430-27E2EBFB-A713-43C7-9581-5746A62E9D2EQ35976610-4EA75C2B-8F9D-404C-970F-EC8907A687FFQ36049510-2C756C74-177D-4C67-A493-1532E295DACDQ47121597-32F2A09B-AE4D-4CBE-93C0-C28CFDAE37A3
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Adrenoleukodystrophy.
@en
type
label
Adrenoleukodystrophy.
@en
prefLabel
Adrenoleukodystrophy.
@en
P2093
P356
P1476
Adrenoleukodystrophy.
@en
P2093
Anna Petroni
Catello Vollono
Sebastiano Banni
P304
P356
10.1159/000321236
P577
2010-12-16T00:00:00Z